Table 2 Most Common Adverse Events (CTCAE G ≥ 2).
Toxicity | Grade 2, n (%) | Grade 3, n (%) | Grade 4, n (%) | Total (%) |
|---|---|---|---|---|
Anemia | 5 (20%) | 4 (16%) | 0 | 36% |
Hypertension | 4 (16%) | 4 (16%) | 0 | 32% |
Fatigue | 4 (16%) | 4 (16%) | 0 | 32% |
Leukopenia | 4 (16%) | 3 (12%) | 0 | 28% |
Depression | 2 (8%) | 3 (12%) | 0 | 20% |
Anxiety | 5 (20%) | 0 | 0 | 20% |
ANC, decreased | 2 (8%) | 3 (12%) | 0 | 20% |
Insomnia | 3 (12%) | 0 | 0 | 12% |
Hypothyroidism | 3 (12%) | 0 | 0 | 12% |
Nausea | 1 (4%) | 1 (4%) | 0 | 8% |
Anorexia | 2 (8%) | 0 | 0 | 8% |
Dizziness | 2 (8%) | 0 | 0 | 8% |
Dyspnea | 2 (8%) | 0 | 0 | 8% |
Cough | 2 (8%) | 0 | 0 | 8% |
Urinary Tract Infection | 2 (8%) | 0 | 0 | 8% |
Thrombocytopenia | 2 (8%) | 0 | 0 | 8% |
